Core Laboratories N.V. (CLB)
Core Laboratories Statistics
Share Statistics
Core Laboratories has 46.7M shares outstanding. The number of shares has increased by -0.16% in one year.
| Shares Outstanding | 46.7M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | -0.26% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 46.18M |
| Failed to Deliver (FTD) Shares | 27 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 6.61M, so 14.11% of the outstanding shares have been sold short.
| Short Interest | 6.61M |
| Short % of Shares Out | 14.11% |
| Short % of Float | 27.37% |
| Short Ratio (days to cover) | 20.32 |
Valuation Ratios
The PE ratio is 26.29 and the forward PE ratio is 12.09. Core Laboratories's PEG ratio is -1.6.
| PE Ratio | 26.29 |
| Forward PE | 12.09 |
| PS Ratio | 1.58 |
| Forward PS | 0.9 |
| PB Ratio | 8.74 |
| P/FCF Ratio | 19.04 |
| PEG Ratio | -1.6 |
Enterprise Valuation
Core Laboratories has an Enterprise Value (EV) of 986.41M.
| EV / Sales | 1.88 |
| EV / EBITDA | 13.42 |
| EV / EBIT | 17.49 |
| EV / FCF | 22.75 |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 1.91.
| Current Ratio | 2.32 |
| Quick Ratio | 1.71 |
| Debt / Equity | 1.91 |
| Debt / EBITDA | 2.45 |
| Debt / FCF | 4.15 |
| Interest Coverage | 4.73 |
Financial Efficiency
Return on Equity is 33.25% and Return on Invested Capital is 8.1%.
| Return on Equity | 33.25% |
| Return on Assets | 5.32% |
| Return on Invested Capital | 8.1% |
| Revenue Per Employee | $149.67K |
| Profits Per Employee | $8.97K |
| Employee Count | 3,500 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 7.33 |
Taxes
| Income Tax | 14.03M |
| Effective Tax Rate | 30.39% |
Stock Price Statistics
The stock price has increased by -26.02% in the last 52 weeks. The beta is 2, so Core Laboratories's price volatility has been higher than the market average.
| Beta | 2 |
| 52-Week Price Change | -26.02% |
| 50-Day Moving Average | 14.82 |
| 200-Day Moving Average | 18.34 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (20 Days) | 415.52K |
Income Statement
In the last 12 months, Core Laboratories had revenue of 523.85M and earned 31.4M in profits. Earnings per share was 0.66.
| Revenue | 523.85M |
| Gross Profit | 88.37M |
| Operating Income | 58.56M |
| Net Income | 31.4M |
| EBITDA | 73.51M |
| EBIT | 58.56M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 19.16M in cash and 180.14M in debt, giving a net cash position of -160.99M.
| Cash & Cash Equivalents | 19.16M |
| Total Debt | 180.14M |
| Net Cash | -160.99M |
| Retained Earnings | 0 |
| Total Assets | 590.41M |
| Working Capital | 129.02M |
Cash Flow
In the last 12 months, operating cash flow was 56.39M and capital expenditures -13.03M, giving a free cash flow of 43.36M.
| Operating Cash Flow | 56.39M |
| Capital Expenditures | -13.03M |
| Free Cash Flow | 43.36M |
| FCF Per Share | 0.91 |
Margins
Gross margin is 16.87%, with operating and profit margins of 11.18% and 5.99%.
| Gross Margin | 16.87% |
| Operating Margin | 11.18% |
| Pretax Margin | 8.82% |
| Profit Margin | 5.99% |
| EBITDA Margin | 14.03% |
| EBIT Margin | 11.18% |
| FCF Margin | 8.28% |
Dividends & Yields
CLB pays an annual dividend of $0.05, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | $0.05 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 7.58% |
| Earnings Yield | 3.8% |
| FCF Yield | 5.25% |
Analyst Forecast
The average price target for CLB is $15.5, which is 23.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.5 |
| Price Target Difference | 23.3% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.49 |
| Piotroski F-Score | 7 |